ResMed Inc. presents a robust portfolio in the healthcare industry with a focus on sleep and respiratory care. Its recent performance indicates a stable fundamental rating supported by strong equity returns. However, its debt-to-equity and price evaluations suggest areas for improvement, warranting close investor attention.
The company's fundamental analysis highlights a strong return on equity and assets, though with lower scores in debt-to-equity and valuation metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical scores show consistency over time, reflecting sustained fundamental strength.
| Date | Overall Score | Discounted Cash Flow | Return on Equity | Return on Assets | Debt to Equity | Price to Earnings | Price to Book |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | 3 | 4 | 5 | 5 | 2 | 2 | 1 |
| Previous | 0 | 4 | 5 | 5 | 2 | 2 | 1 |
Analyst estimates reveal a stable market view with the median price target aligning well with consensus recommendations.
| High | Low | Median | Consensus |
|---|---|---|---|
| 305 | 280 | 299.5 | 296 |
The stock maintains a promising sentiment with a strong bias towards 'Buy' recommendations.
| Recommendation | Number | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 17 | |
| Hold | 12 | |
| Sell | 5 | |
| Strong Sell | 0 |
ResMed Inc. shows promising potential in the healthcare sector with robust returns on investment metrics. However, its valuation metrics and debt levels suggest some caution. The company's consistent historical performance adds confidence, yet careful monitoring of pricing strategies and debt management is advised. Analyst sentiment remains favorable, reinforcing its attractiveness as a strong long-term investment opportunity.